About 1 result found for searched term "1905409-39-3" (0.121 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24845 | Mosunetuzumab | CD20 |
| BTCT-4465A | ||
| Mosunetuzumab (BTCT-4465A) is a humanized, immunoglobulin G1-based bispecific antibody targeting CD20 (B cells) and CD3 (T cells). Mosunetuzumab redirects T cells to engage and eliminate malignant B cells and can be used for the research of relapsed or refractory (R/R) B-cell non-Hodgkin lymphomas (B-NHLs). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
